ORGANIC
LETTERS
2010
Vol. 12, No. 1
136-139
An Oxidation and Ring Contraction
Approach to the Synthesis of
(()-1-Deoxynojirimycin and
(()-1-Deoxyaltronojirimycin
Sharan K. Bagal,† Stephen G. Davies,*,‡ James A. Lee,‡ Paul M. Roberts,‡
Angela J. Russell,‡ Philip M. Scott,‡ and James E. Thomson‡
Department of Chemistry, Chemistry Research Laboratory, UniVersity of Oxford,
Mansfield Road, Oxford OX1 3TA, U.K., and Pfizer Global R&D, Sandwich,
Kent CT13 9NJ, U.K.
Received November 2, 2009
ABSTRACT
A reaction sequence involving the chemoselective olefinic oxidation of N(1)-benzyl-2,7-dihydro-1H-azepine with m-CPBA in the presence of
HBF4 and BnOH followed by ring contraction facilitates the stereoselective preparation of either of the epoxide diastereoisomers of (2RS,3SR)-
N(1)-benzyl-2-chloromethyl-3-benzyloxy-4,5-epoxypiperidine by simple modification of the reaction conditions. Epoxide ring opening, functional
group interconversion, and deprotection allow the synthesis of (()-1-deoxynojirimycin and (()-1-deoxyaltronojirimycin.
Polyhydroxylated piperidines have received considerable at-
tention from the synthetic community due to their glycosidase
inhibitory properties,1 which give them great potential in the
treatment of a variety of disorders including cancer and HIV.2
As part of an ongoing research program directed toward the de
novo preparation of imino and amino sugars and their deriva-
tives,3 we recently reported the ammonium-directed oxidation
of 3-(N,N-dibenzylamino)cyclohex-1-ene 1 upon treatment with
m-CPBA in the presence of Cl3CCO2H.4 Regioselective in situ
ring opening of the intermediate epoxide 2 gave trichloroacetate
ester 3, which underwent transesterification to give diol 4 in
quantitative yield and 95:5 dr (Scheme 1). Herein, the applica-
tion of this methodology to the stereoselective synthesis of (()-
1-deoxynojirimycin (and its diastereoisomer (()-1-deoxyal-
tronojirimycin) using a strategy reliant on oxidation of N(1)-
benzyl-2,7-dihydro-1H-azepine and ring contraction is reported.
N(1)-Benzyl-2,7-dihydro-1H-azepine 10 was prepared ac-
cording to a modification of the procedure reported by Walsh
and co-workers.5 Methylation of (Z,Z)-hexa-2,4-dienedioic
(3) For selected recent examples, see: (a) Aciro, C.; Davies, S. G.;
Roberts, P. M.; Russell, A. J.; Smith, A. D.; Thomson, J. E. Org. Biomol.
Chem. 2008, 6, 3762. (b) Davies, S. G.; Durbin, M. J.; Goddard, E. C.;
Kelly, P. M.; Kurosawa, W.; Lee, J. A.; Nicholson, R. L.; Price, P. D.;
Roberts, P. M.; Russell, A. J.; Scott, P. M.; Smith, A. D. Org. Biomol.
Chem. 2009, 7, 761. (c) Aciro, C.; Davies, S. G.; Kurosawa, W.; Roberts,
P. M.; Russell, A. J.; Thomson, J. E. Org. Lett. 2009, 11, 1333. (d) Bond,
C. W.; Cresswell, A. J.; Davies, S. G.; Fletcher, A. M.; Kurosawa, W.;
Lee, J. A.; Roberts, P. M.; Russell, A. J.; Smith, A. D.; Thomson, J. E. J.
Org. Chem. 2009, 74, 6735.
† Pfizer Global R&D.
‡ University of Oxford.
(1) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron:
Asymmetry 2000, 11, 1645. Davis, B. G. Tetrahedron: Asymmetry 2009,
20, 652.
(2) For instance, see: Cross, P. E.; Baker, M. A.; Carver, J. P.; Dennis,
J. W. Clin. Cancer Res. 1995, 1, 935. Qian, X.; Moris-Varas, F.; Fitzgerald,
M. C.; Wong, C.-H. Bio. Med. Chem. 1996, 4, 2055. Nakagawa, K.; Kubota,
H.; Tsuzuki, T.; Kariya, J.; Kimuro, T.; Oikawa, S.; Miyazawa, T. Biosci.
Biotechnol. Biochem. 2008, 72, 2008. Winchester, B. G. Tetrahedron:
Asymmetry 2009, 20, 645.
(4) Aciro, C.; Claridge, T. D. W.; Davies, S. G.; Roberts, P. M.; Russell,
A. J.; Thomson, J. E. Org. Biomol. Chem. 2008, 6, 3751.
10.1021/ol902533b 2010 American Chemical Society
Published on Web 12/02/2009